Atlas Trials

Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning

Clinical trial NCT00466674 · COMPLETED

Trial details

NCT number
NCT00466674
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloma
Start date
2007-01-01
Primary completion
2013-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.